Used in the treatment of chronic hepatitis B infection, HEPC helps reduce the amount of virus in the body by inhibiting viral replication. It supports improved liver function and decreases the risk of liver damage, cirrhosis, and hepatocellular carcinoma in affected patients. Commonly prescribed in long-term antiviral therapy, it is effective in both HBeAg-positive and HBeAg-negative forms of the disease. Its oral formulation allows for convenient daily dosing, making it a preferred option in managing chronic HBV.